Use of Network Pharmacology to Investigate the Mechanism of the Compound Xuanju Capsule in the Treatment of Rheumatoid Arthritis

Objective To clarify the therapeutic mechanisms of compound Xuanju capsule-treated rheumatoid arthritis (RA) based on network pharmacology tactics. Method The TCMSP, TCMID and STITCH databases were used to screen the active ingredients and targets in the compound Xuanju capsule; the OMIM, TTD, PharmGKB and GeneCards databases were applied to screen the RA-related disease targets. Then, the obtained targets were imported into Cytoscape 3.7.1 software to construct the active ingredient-target network and the RA-related disease-target network. The active ingredient-target PPI network, the RA-related disease-target PPI network and the common target PPI network were built by using the STRING platform and Cytoscape 3.7.1 software. The GO and KEGG analyses of the common targets were analyzed by using the Metascape and Bioinformatics online tools. Results A total of 51 active ingredients and 513 corresponding ingredient targets were harvested from the compound Xuanju capsule; 641 RA-related disease targets were obtained. After two PPI networks were constructed and merged, 116 RA-related targets of compound Xuanju capsules were identified and analyzed. 116 RA-related targets of compound Xuanju capsules are mainly involved in the biological processes and molecular functions, such as the cytokine-mediated signaling pathways, the response to lipopolysaccharide and the blood vascular development, the cytokine activity, the cytokine receptor binding and the receptor regulator activity. Furthermore, 116 RA-related targets of compound Xuanju capsules are concentrated in signaling pathways such as the IL-17, TNF, Th17 cell differentiation, Toll receptor and RA signaling pathway. Conclusion The compound Xuanju capsule had the action characteristics of multiple components, multiple targets, and multiple pathways in the treatment of RA, which might primarily reduce the release of proinflammatory factors (such as IL-6 and TNF-α) and increase the production of anti-inflammatory factors (such as IL-10) by regulating inflammation-related signaling pathways (such as IL-17), thereby alleviating the inflammatory damage and improving the bone tissue repair.


Introduction
Rheumatoid arthritis (RA), a common autoimmune dysfunction disease characterized by the chronic inflammation of the joint synovium and the systemic vasculitis, can severely impair the physical function and the quality of life [1]. Worldwide, approximately 1% of the population is affected by RA, and the RA prevalence in women is about three times higher than that in men [2]. The pathogenesis of RA is relatively complicated and related to immune imbalance, genetic factors, environment factors, and so on, in which the participation of cytokines plays an important role [3,4]. The com-mon therapeutic drugs for RA include the nonsteroidal antiinflammatory drugs, the disease-modifying antirheumatic drugs, glucocorticoids and biologic agents. While these drugs are taken, there are also the long-term side effects such as increased risk of infection and potential fatal liver damage [5]. Traditional Chinese Medicine (TCM) has been used to treat RA for more than three thousands of years in China. Modern pharmacological researches demonstrated that the effective active ingredients in Chinese medicine could weaken the activity of RA and protect joints from deformity [6]. In TCM theory, RA belongs to the category of therapeutic concept "Bi Zheng ", which is related to the deficiency of vital qi as well as the invasion of "wind (feng)", "cold (han)", "damp (shi)", "stasis (yu)" and other evil qi [7,8]. TCM can regulate the body function as a whole through a multifaceted approach and multiple mechanisms [9], therefore, it usually adopts the principles of warming the meridian, dispersing the cold and relieving the pain in RA treatment.
The compound Xuanju capsule, as a Chinese patent medicine, is composed of black ants (XJ), Herba Epimedii (Epimedium brevicornu Maxim., YYH), Fructus Cnidii (Cnidium monnieri (L.) Cuss., SCZ), and Fructus Lycii (Lycium barbarum L., GQZ). The black ants, as the primary drug, can nourish the kidney and liver, invigorate the circulation of blood and remove blood stasis, drive wind, and disperse cold [10]. Herba Epimedii, as the subject drug, can tonify the kidney, strengthen yang, and dispel wind and dampness [11]. Fructus Cnidii, as the adjuvant drug, can warm the kidney, invigorate yang, and dissipate cold [12]. Fructus Lycii, as the envoy drug, can tonify the liver and kidney and firm bones [13]. The combined use of four drugs has a good therapeutic effect on RA in clinical practice by warming and tonifying kidney-yang and removing wind and cold [14]. In addition, the compound Xuanju capsule could inhibit Th17 cells to secrete IL-17, while the secretion of Th17 and IL-17 played an important role in the pathogenesis of RA [15]. Furthermore, earlier researches have shown that the compound Xuanju capsule had the immunomodulatory and anti-inflammatory effects [16]. It had a significant inhibitory effect on the phagocytic function of the reticuloendothelial system and the delayed allergic reaction in mice and significantly inhibited the increase in the amount of abdominal exudate and the number of white blood cells induced by carboxymethyl cellulose stimulation. At the same time, it could also inhibit the formation of cotton ball granulation tissue. Modern pharmacological studies have also found that black ants contained rich formic acid and a variety of trace elements, had obvious anti-inflammatory effect, could reduce the tissue damage, and eliminate free radicals to promote bone formation [17]; icariin, the core component of Epimedii, could inhibit the inflammatory response and the synthesis of inflammatory substances and enhance the nonspecific immune function and cellular immunity [18]; osthole, a bioactive coumarin compound, was mainly contained in Fructus Cnidii and could significantly inhibit the release of inflammatory cytokines TNF-α and IL-6 and the inflammatory mediator NO [19]. However, the pharmacodynamic basis and more molecular mechanism of compound Xuanju capsule-treated RA are still unknown.
The network pharmacology method of TCM based on the analysis of network big data can effectively uncover the potential compatible action mechanism of drugs, thus providing a powerful tool for accelerating the modernization of TCM research and development [20]. In the present study, the method of TCM network pharmacology was adopted to further analyze the potential active ingredient, related targets and molecular signaling pathways of compound Xuanju capsule-related RA, with the aim of providing more theoretical basis for the effectiveness of compound Xuanju capsuletreated RA.

Screening of Active Ingredients of the Compound Xuanju
Capsule. The active ingredients of black ants (XJ), Herba Epimedii (YYH), Fructus Lycii (SCZ) and Fructus Cnidii (GQZ) in the whole prescription were collected by the Traditional Chinese Medicine Systems Pharmacology (TCMSP) database and analysis platform (http://lsp.nwu.edu.cn/tcmsp.php), Traditional Chinese Medicine Integrated Database (TCMID, http://www.http://megabionet.org/tcmid), Natural Products Database of Traditional Chinese Medicine of Shanghai Institute of Organic Chemistry (http://www.chemcpd.csdb.cn) and the related literature of the compound Xuanju capsule [21,22]. According to the integrative absorption, distribution, metabolism and excretion (ADME) model, bioavailability (OB) and drug-likeness (DL) were regarded as the screening criteria for active ingredients. The active ingredients were remained which were satisfactory with criteria of OB ≥ 30% and DL ≥ 0:18 for further study [23].

Prediction and Visualization of Active Ingredient-Potential Targets.
To obtain the target of the each active ingredient in the compound Xuanju capsule, the potential targets were predicted from the TCMSP and STITCH databases (https://string-db.org). And then, the targets corresponding to the active ingredients screened from the two target databases were standardized in the UniProt database (http://www.uniprot.org), with the properties set to "reviewed" and "human" [24]. Subsequently, these standardized targets were merged and the duplicated items were removed. Finally, an active ingredient-target network was constructed using Cytoscape 3.7.1 software, and the network topology analysis was carried out. The degree, a topological parameter, was applied to screen the kernel active ingredients and the corresponding targets of the compound Xuanju capsule.

Prediction and Visualization of RA-Related Disease
Targets. With "Rheumatoid arthritis" to be the keyword, RA-related targets were retrieved from three public online databases, namely, the Therapeutic Target Database (TTD, http://bidd.nus.edu.sg/group/cjttd), the PharmGKB database (https://www.Pharmgkb.org), the Online Mendelian Inheritance in Man (OMIM) database (http://www.omim.org) and the GeneCards database (https://www.genecards.org) [25,26]. These targets were also sent to the UniProt database for normalization, and then, the duplicate targets were removed. Eventually, the RA-related disease target network was built by using Cytoscape 3.7.1 software as well.

Construction of the Protein-Protein Interaction (PPI)
Network and Screening of the Common Targets. The active ingredient targets of the compound Xuanju capsule and the RA-related disease targets were analyzed using the STRING database, and "Homo sapiens" was limited. Two PPI networks of the active ingredient targets of the compound Xuanju capsule and the RA-related disease targets were built and merged through Cytoscape 3.7.1 software. Afterward, the common network (the intersection part of two PPI networks) was further analyzed by using Cytoscape 3.7.1 2 BioMed Research International software, and the common targets were obtained. Additionally, we further screened targets whose degree value ranked in the top 20 as the core targets of compound Xuanju capsule-related RA.

Enrichment Analysis of the Common Targets. The Gene
Ontology (GO) [27] biology process annotation and the Kyoto Encyclopedia of Genes and Genomes (KEGG) [28] pathway enrichment analysis of the common targets were carried out through the Metascape online database (http:// metascape.org), which got the potential signal pathways, related biological processes, cell components, and molecular functions of the active components in the compound Xuanju capsule. The results of GO enrichment analysis and the bubble diagram of KEGG pathway enrichment were drawn using the Bioinformatics online tools (http://www.bioinformatics .com.cn). The ClueGO plug-in in Cytoscape 3.7.1 software was applied for constructing the visual results of the target proteins involved in signal pathways.

Collection of Active Ingredients of the Compound Xuanju
Capsule. In the present study, we searched all the reported chemical components in the compound Xuanju capsule through TCMSP, TCMID, and Natural Products Database of Traditional Chinese Medicine of Shanghai Institute of Organic Chemistry. A total of 478 ingredients were collected, among which 46 was found in black ants, 130 in Epimedium, 114 in Fructus Cnidii, and 188 in wolfberry. According to the screening criteria of the ADME, including the OB and DL, 87 active ingredients of the compound Xuanju capsule were    BioMed Research International obtained after duplicated targets were removed. In addition, three antirheumatic active ingredients of Xuanju were found from literatures, namely, citral, formic acid, and β-sitosterol [29]. Including all the above active ingredients, a total of 90 active ingredients of the compound Xuanju capsule were obtained.

Active Ingredient-Potential Targets and the Visualized
Network. STITCH and TCMSP databases were used to predict the targets of the active ingredients. After the "Homo sapiens" targets were remained and the duplicated targets were removed, 51 active ingredients and 513 corresponding action targets were screened, as shown in Table 1. The above targets were imported into Cytoscape 3.7.1 software to construct the active ingredient-target network diagram ( Figure 1). The network contained 570 important nodes and 936 edges. Among them, the formic acid, quercetin, kaempferol, luteolin, and stigmasterol had higher degree values, PTGS2, PTGS1, PRKACA, GABRA1 and RXRA tar-gets had higher degree values. The top 10 active ingredients and the corresponding targets are shown in Table 2.

RA-Related Disease Targets and the Visualized Network.
Searching for RA-related targets through TTD, PharmGKB, OMIM and GeneCards databases, when "Homo sapiens" targets were remained and the duplicated targets were removed, a total of 641 targets were obtained. The above targets were submitted in the Cytoscape 3.7.1 software to construct the RA-related disease-target network ( Figure 2).

PPI Network Topology
Analysis. The STRING online database was used for PPI network topology analysis. The analyzed PPI relationship data results (.tsv format file) were imported into the Cytoscape 3.7.1 software, and then, the visualized PPI network of the active ingredient targets ( Figure 3) and the PPI network of RA-related disease targets ( Figure 4) were obtained. Among them, the PPI network of the active ingredient targets involved 500 nodes (interaction  Figure 3: The PPI network of the active ingredient targets that consists of 500 nodes and 9488 edges. The yellow rounds represent the protein targets acted by the active ingredient, and the black lines denote the interaction relationship between the protein targets. 6 BioMed Research International proteins) and 9488 edges (interaction relationships); the PPI network of RA-related disease targets involved a total of 625 nodes (interaction proteins) and 19389 edges (interaction relationships).
3.5. Screening of the Common Targets. In the Cytoscape 3.7.1 software, the CytoNCA plug-in was applied to merge two PPI networks and obtain a visualized intersection target network ( Figure 5), which consisted of 116 common nodes and 2241 edges. As shown in Figure 5, these key targets were highly correlated in the potential target network relationship of compound Xuanju capsule-treated RA, including IL-6, VEGFA, TNF, AKT1, MAPK3, CXCL8, IL10, IL1β, JUN and CASP3. The 116 common targets were ranked according to the degree value, and the top 20 core targets of compound Xuanju capsule-related RA are shown in Table 3.  Figure 6. The GO-MF analysis indicated that the core targets of compound Xuanju capsule-related RA mainly affected the cytokine activity, the receptor regulator activity, the receptor ligand activity, cytokine receptor binding, phosphatase binding, transcription factor binding, and other molecular functions in the treatment of RA. The GO-BP analysis showed that the core targets of compound Xuanju capsule-related RA could be involved in a majority of biological processes in the treatment of RA, such as the cytokine-mediated signaling pathways, the response to lipopolysaccharide, the response to molecule of bacterial origin, the response to bacterium, the  The GO-CC analysis indicated that the core targets of compound Xuanju capsule-related RA were primarily enriched in the membrane rafts, the membrane microdomain, the cytoplasmic vesicle lumen, the secretory granule lumen, the extracellular matrix and so on.
3.7. KEGG Pathway Analysis. The KEGG pathway analysis was carried out to further explore which pathways were related to the screened common targets. Among the top 20 pathways (sorted by the degree value), there were mainly the IL-17 signaling pathway, the TNF signaling pathway, the Th17 cell differentiation pathway, the Toll receptor signaling pathway, the RA pathway, the fluid shear stress and atherosclerosis pathway, and so on (Figure 7). Using the ClueGO plug-in in Cytoscape 3.7.1 software, the visualization results of the signal pathway of the target proteins involved were constructed. It was found that the efficacy of the compound Xuanju capsule was mainly achieved by regulating the IL-17 signaling pathway, the TNF signaling pathway, the Th17 cell differentiation pathway, the Toll receptor signaling pathway, and so on, as shown in Figure 8

Discussion
Network pharmacology is a research method to clarify the disease occurrence and development from the perspectives of systems biology and biological networks, through the collection of ingredients and action targets; an interaction network is constructed to further investigate the regulation effect of TCM on different signals, thereby revealing the action mechanism of TCM [30]. Based on the network pharmacology tactics, this study deeply explored the potential  Figure 5: The common target PPI network that consists of 116 nodes and 2241 edges. The 116 rounds represent the potential protein targets of compound Xuanju capsules against RA, and the black lines denote the interaction relationship between the protein targets. The color and size of the round indicate the size of the degree value; the degree value corresponds to the round color from yellow to purple. 8 BioMed Research International mechanism of the Chinese patent medicine compound Xuanju capsule in the treatment of RA. 51 active ingredients of compound Xuanju capsules, such as formic acid, quercetin, kaempferol, luteolin and stigmasterol, were screened through multiple large databases. It was predicted that there were 116 potential targets of the compound Xuanju capsule in the treatment of RA, such as IL-6, GAPDH, VEGFA, TNF and AKT1. Five potential mechanism pathways of compound Xuanju capsule-treated RA were analyzed and summarized, namely, the IL-17 signaling pathway, the TNF signaling pathway, the Th17 cell differentiation pathway, the Toll receptor signaling pathway and the RA pathway. Among the 51 active ingredients selected in this work, formic acid, quercetin, kaempferol, luteolin, stigmasterol, anhydroicaritin and so on were the top 10 active ingredients according to the degree value, which might be the main active ingredients of the compound Xuanju capsule against RA. Researches have demonstrated that formic acid as one of the biologically active substances of black ants was the material basis for its anti-inflammatory, analgesic, antibacterial and antirheumatic effects and immune regulation and prevention of arteriosclerosis [17,31]. Quercetin can improve morning stiffness, arthralgia, and other clinical symptoms of RA patients and reduce disease activity scores [32]. Kaempferol can inhibit the migration and invasion of fibroblast-like synovial cells in RA by blocking the activation of the MAPK pathway and inhibit the reorganization of the actin cytoskeleton during cell migration, thereby reducing the arthritis symptoms of collagen-induced arthritis rats [33]. Luteolin can reduce the proliferation of fibroblast-like synovial cells in RA by inhibiting the NF-κB and JAK/STAT signal pathways [34]. Stigmasterol is a natural plant product with anti-inflammatory activity, which can inhibit the signal pathway of the inflamed joints, improve the antioxidant status, and transfer inflammation [35]. Anhydroicaritin has the function of repairing the bone tissue; in addition, it can promote the angiogenesis by increasing the expression of proangiogenic factors such as VEGFA and McP-1, thus providing more nutrients for bone formation [36]. Therefore, the above-mentioned active ingredients might be all the medicinal material bases of the compound Xuanju capsule in the treatment of RA, which had an important reference value for subsequent clinical and experimental research.
Each node in the network represents the protein corresponding to the action target; thus, 116 common nodes involved in the intersection network indicated that there were a total of 116 potential action targets of the compound Xuanju capsule in the treatment of RA. Additionally, the size and color of the nodes represent the degree value of the target protein, and the connection between the nodes represents the potential interaction between the target proteins [37]. The target protein in the network relationship is greatly correlated with the node size, the node color, and the connections, which increase with them [38]. Hence, IL-6, VEGFA, TNF, AKT1, MAPK3, CXCL8, IL10, IL1β, JUN, CASP3 and other targets showed an obvious correlation in the network relationship of compound Xuanju capsules in the treatment of RA, as shown in Figure 5. This demonstrated that the 9 BioMed Research International compound Xuanju capsule had higher binding activity with these targets which could be used as the potential action targets. It had shown that TNF-α was increased in the synovium and cartilage of RA patients, which could promote the cartilage destruction by inhibiting the collagen synthesis, stimulating the fibroblasts and chondrocytes to produce the prostaglandins and collagenase, stimulating the chondrocytes to secrete metalloproteinases, inducing the differentiation of peripheral blood mononuclear cells into osteoclasts, etc. [39]. Meanwhile, TNF-α can increase the production of the proinflammatory factors (IL1β, IL-6, etc.) and chemokines (CXCL8, etc.) through the cascade reaction and further aggravate the inflammatory response [40]. IL-6 is a major inflammatory mediator and induced osteoclast precursors to differentiate into the real osteoclasts during bone metabolism [41]. Thus, IL-6 is the main factor for further destruction of bone and cartilage. As the negative regulator of the proinflammatory cytokines, 1L-10 can reduce the release of the proinflammatory cytokines [42]. One of the earliest observed phenomena in synovitis is the formation of new blood vessels. VEGF is the key molecule involved in the reg-ulation of angiogenesis which can promote the infiltration of inflammatory cells into the joint and lead to synovial hyperplasia and progressive bone destruction [43,44]. AKT1 is believed to be closely related to the production of RA synovial fibroblasts [45]. The MAPK gene participates in signaling pathways that can reduce the oxygen free radicals, inhibit the cell proliferation, promote the apoptosis, reduce the inflammatory response, and inhibit the angiogenesis, thus effectively inhibiting RA progression [46]. JUN, closely associated with the proliferation, differentiation, maturation, and function of the osteoblast, plays an important role in maintaining the dynamic balance of bone formation and bone resorption [38]. The results of the current study showed that the known active ingredients of the compound Xuanju capsule could primarily act on 116 targets in the treatment of RA. Among the 116 targets, IL-6, VEGFA, TNF, AKT1, MAPK3, CXCL8, IL10, IL1β, MAPK8, JUN and other targets had higher degree values, indicating that these targets might be the core targets of the compound Xuanju capsule against RA, and the corresponding action mechanism was characterized by multiple components and multiple targets.   The GO and KEGG pathway enrichment analysis were conducted on 116 common targets. The GO results found that the cytokine activity and the cytokine receptor binding were closely related to the occurrence of RA in terms of molecular functions. In addition, the signal pathways and vascular development mediated by the cytokines in biological processes had a certain impact on RA; this was also corroborated with the results that the compound Xuanju capsule might act on 166 potential core targets in the treatment of RA. KEGG pathway enrichment analysis results demonstrated that the main signaling pathways regulated by the compound Xuanju capsule were the IL-17 signaling pathway, the TNF signaling pathway, the Th17 cell differentiation pathway, the Toll receptor signaling pathway, the RA pathway, the liquid shear stress and atherosclerosis pathways, etc. It had shown that the TNF signaling pathway was the key pathway derived from the enrichment analysis and an important pathway in the inflammatory response [47]. The occurrence and development of RA are related to the abnormal expression of IL-6, IL1β, TNF and PTGS2 in the TNF signaling pathway [48]. IL-17 not only causes the inflammation but also stimulates the osteoclast differentiation to cause bone and cartilage damage. At the same time, IL-17 can also stimulate the production of many types of chemokines and aggravate the inflammatory response. Furthermore, IL-17  can induce the prostaglandins to enter the inflammatory sites through the cyclooxygenase-2 and then damage the synovial surface and articular cartilage [49]. Therefore, the IL-17 signaling pathway plays an important role in the course of RA. The RA pathway includes the T cell receptor signaling pathway, the Toll receptor signaling pathway, the VEGF signaling pathway, the osteoclast differentiation, and the Th17 cell differentiation, all of which are related to the immune regulation and inflammation. Among them, the abnormal T cell-mediated immune response is the main pathogenesis of RA. In the diseased synovial tissue, a large number of activated T lymphocytes gather around the blood vessels. The activated T lymphocytes interact directly with synovial macrophages, secrete the cytokines, and stimulate the synovial cells to release collagenase and protease, which further caused the cartilage and bone damage [38]. The Toll receptor signaling pathway directly triggers the intracellular bactericidal mechanism or induces the production of immune inflammatory factors on the basis of identifying pathogenic microorganisms to expand nonspecific defenses. Research manifested that the Toll receptors were significantly expressed in the pathological tissues of RA patients [50]. The VEGF signaling pathway inhibits the expression of cytokines in arthritis, reduces the production of collagen, inhibits the proliferation of synovial cells, and weakens the invasion ability [41]. Th17 and Treg cells are two subtypes of CD4 + T cells. Among them, Th17 cells can highly secrete inflammatory cytokines such as IL-17, IL-6 and IL-22, mediating inflammatory reactions and autoimmune reactions in the body [51]. Abnormal activation of Th17 cells will cause the imbalance of Th17/Treg cells and play a key role in autoimmune diseases such as RA, especially in local inflammatory response and bone destruction, while long-term local inflammation will induce and worsen the destruction of RA articular cartilage [52]. Cells in the body can not only sense the stimulation of various chemical factors in the external environment but also live in various mechanical environments, such as the pressure of fluid as well as shear stress caused by the fluid flow. In the interaction between the extracellular matrix and the signal molecules on the cell membrane, these mechanical stresses can be sensed by cells, thereby activating intracellular signaling pathways, transforming the mechanical signals into the intracellular biochemical signals, and thus affecting cell shape, adhesion and migration, gene expression, differentiation, and even cell death [53]. These mechanical factors play a decisive role in the changes of cellular functions such as cardiovascular disease, bone formation, and organ development. The present study results indicated that the main signaling pathways regulated by the compound Xuanju capsule included the IL-17 signaling pathway, the TNF signaling pathway, the Toll receptor signaling pathway, the Th17 cell differentiation pathway, the RA pathway and the liquid shear stress and atherosclerosis pathway. Furthermore, the inflammatory signal pathways were the main pathway. This suggested that the compound Xuanju capsule might mainly regulate the inflammatory pathways to protect the bone tissue and improve the clinical symptoms of RA patients such as joint swelling and pain. Moreover, the above research results predicted by the network pharmacology method were mutually confirmed with the observation results of the compound Xuanju capsule in the clinical treatment of RA [14,15]. RA is a chronic inflammatory autoimmune disease with the complex pathogenesis [35]. The results of the present study suggested that RA was related to the abnormality of the IL-6-based multitarget and IL-17 pathway-based multisignal pathways; thus, the pathogenesis of RA had the characteristics of multitarget and multipathway. To some extent, it explained the phenomenon that there was no good effect in the single target treatment of the disease in clinic. TCM has the characteristics and advantages of multicomponent, multitarget, and multipathway in the treatment of diseases. Therefore, it is still a research hotspot to find drugs for RA treatment.
In conclusion, based on the network pharmacology methods, the current study found that the compound Xuanju capsule, in the treatment of RA, might mainly act on 116 targets based on IL-6 through 51 active ingredients such as formic acid, quercetin and kaempferol, and then regulated the IL-17 signal pathway, the TNF signal pathway, the Th17 cell differentiation pathway, the Toll receptor signaling pathway, the RA pathway, etc., to further affect the release of the proinflammatory factors and the anti-inflammatory factors, thereby alleviating inflammatory damage and improving bone tissue repair. The above results reflected the mechanism and advantages of the compound Xuanju capsule in treating RA with multiple components, multiple targets, and multiple pathways, and also confirmed that inhibiting the secretion of inflammatory factors was one of its major mechanisms.

Data Availability
We have presented all our main data in the form of figures and tables. The datasets supporting the conclusions of this article are included within the article.

Conflicts of Interest
The authors declare that there are no conflicts of interest.

Authors' Contributions
Wenyang Wei was responsible for data analysis and original diagram preparation. Wenyang Wei, Wanpeng Lu, and Xiaolong Chen wrote the manuscript. Yunfeng Yang supervised the whole research. Wenyang Wei and Mengkai Zheng revised the manuscript.